G. Wood

发表

p53 tumor suppressor gene mutations in transformed cutaneous T‐cell lymphoma: A study of 12 cases

A. Marrogi, M. A. Khan, E. Vonderheid, 1999, Journal of cutaneous pathology.

T cell subpopulations in alopecia areata.

R. Turner, G. Wood, N. Todes-Taylor, 1984, Journal of the American Academy of Dermatology.

Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).

R. Advani, L. Wilson, G. Wood, 2011, Journal of the American Academy of Dermatology.

European Organization of Research and Treatment of Cancer (EORTC) Lymphomas (ISCL) and the cutaneous lymphoma task force of the Sézary syndrome: a proposal of the International Society for Cutaneous Revisions to the staging and classification of mycosis fungoides and

R. Dummer, G. Burg, N. Pimpinelli, 2009 .

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

Nicola Pimpinelli, Reinhard Dummer, Peter Heald, 2007, Blood.

Mycosis fungoides: Clinical and histologic features, staging, evaluation, and approach to treatment

G. Wood, R. Hoppe, E. Abel, 1993, CA: a cancer journal for clinicians.

Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides.

R. Levy, L. Steinman, G. Wood, 1991, Blood.

Skin, reactive oxygen species, and circadian clocks.

G. Wood, M. Nihal, N. Ahmad, 2014, Antioxidants & redox signaling.

The varied histopathology of lymphadenopathy in the homosexual male

G. Wood, B. Burns, R. Dorfman, 1985, The American journal of surgical pathology.

A Venn diagram model that allows triple-label immunophenotypic analysis of cells based upon double-label measurements.

G. Wood, 1989, American journal of clinical pathology.

Anti‐proliferative and proapoptotic effects of (−)‐epigallocatechin‐3‐gallate on human melanoma: Possible implications for the chemoprevention of melanoma

H. Mukhtar, G. Wood, M. Nihal, 2005, International journal of cancer.

Microsatellite instability in human melanocytic skin tumors: an incidental finding or a pathogenetic mechanism?

G. Wood, M. Hussein, 2002, Journal of cutaneous pathology.

Immunoglobulin gene rearrangements in hairy cell leukemia.

R. Warnke, J. Sklar, M. Cleary, 1984, Blood.

Leu-8 and Leu-9 antigen phenotypes: immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation.

R. Warnke, G. Wood, R. Hoppe, 1986, Journal of the American Academy of Dermatology.

Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium.

G. Wood, J. Beckstead, V. Fletcher, 1985, The American journal of pathology.

Human dendritic cells and macrophages. In situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics.

R. Warnke, R. Turner, L. Eng, 1985, The American journal of pathology.

Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea.

R. Agarwal, H. Mukhtar, G. Wood, 1992, Cancer research.

Protection against 12-O-tetradecanoylphorbol-13-acetate-caused inflammation in SENCAR mouse ear skin by polyphenolic fraction isolated from green tea.

S. Ekker, R. Agarwal, H. Mukhtar, 1993, Carcinogenesis.

Isolation, detection, and amplification of intact mRNA from dermatome strips, epidermal sheets, and sorted epidermal cells.

S. Hufeisen, G. Wood, R. Eckert, 1991, Journal of Investigative Dermatology.

Quantitative gene analysis of methylation and expression (Q‐GAME) in fresh or fixed cells and tissues

B. Longley, G. Wood, V. Spiegelman, 2014, Experimental dermatology.

Multispectral Imaging Approach to the Diagnosis of a CD20+ Cutaneous T-cell Lymphoproliferative Disorder: A Case Report

G. Wood, J. Guitart, D. Bennett, 2015, The American Journal of dermatopathology.

Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?

J. Scarisbrick, G. Wood, S. Whittaker, 2014, The British journal of dermatology.

Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome

H. Vogel, G. Wood, Shufeng Li, 2017, Journal of Neuro-Oncology.

Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event.

L. Gordon, J. Winter, B. Coiffier, 2013, Blood.

large-cell lymphoma disorders: lymphomatoid papulosis and primary cutaneous anaplastic treatment of primary cutaneous CD30-positive lymphoproliferative EORTC, ISCL, and USCLC consensus recommendations for the

R. Dummer, L. Cerroni, B. Dréno, 2012 .

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

R. Dummer, L. Cerroni, B. Dréno, 2011, Blood.

Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma.

G. Wood, Jianqiang Wu, 2011, Archives of dermatology.

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.

R. Advani, G. Wood, S. Horwitz, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis

G. Wood, M. Nihal, N. Ahmad, 2011, Cell cycle.

Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes.

R. Warnke, G. Wood, L. Weiss, 1989, American journal of clinical pathology.

The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients.

R. Warnke, S. Horning, G. Wood, 1984, The American journal of pathology.

Angiocentric non-Hodgkin’s lymphoma of the leg

G. Wood, M. Hinshaw, 2006 .

Diagnosis, staging, and monitoring of cutaneous T‐cell lymphoma

G. Wood, H. L. Greenberg, 2003, Dermatologic therapy.

Solitary Primary Cutaneous CD30+ Large Cell Lymphoma of Natural Killer Cell Phenotype Bearing the t(2;5)(p23;q35) Translocation and Presenting in a Child

G. Wood, J. Goldstein, D. Mikkola, 2000, The American Journal of dermatopathology.

The clonality of tumor‐infiltrating lymphocytes in African Kaposi’s sarcoma

G. Wood, M. Nihal, S. Remick, 2001, Journal of cutaneous pathology.

Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study

G. Wood, Jianqiang Wu, 2018, JAMA dermatology.

Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma.

R. Warnke, J. Sklar, G. Wood, 1993, The Journal of investigative dermatology.

Chitosan-based nanoformulated (−)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis

S. Mousa, V. Adhami, H. Mukhtar, 2018, International journal of nanomedicine.

Prodifferentiation, Anti-Inflammatory and Antiproliferative Effects of Delphinidin, a Dietary Anthocyanidin, in a Full-Thickness Three-Dimensional Reconstituted Human Skin Model of Psoriasis

C. Elmets, V. Adhami, H. Mukhtar, 2015, Skin Pharmacology and Physiology.

Topical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammation

C. Elmets, V. Adhami, H. Mukhtar, 2015, The British journal of dermatology.

Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma.

B. Smoller, G. Wood, D. Fivenson, 1996, The Journal of investigative dermatology.

Endothelial cell phenotypic diversity. In situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes.

R. Warnke, R. Turner, G. Wood, 1987, American journal of clinical pathology.

Morphological Changes and Apoptosis in Radial Growth Phase Melanoma Cell Lines Following Ultraviolet-B Irradiation

G. Wood, M. Hussein, Medhat O. Hassan, 2003, The American Journal of dermatopathology.

Anti-Melanoma Effects of Vorinostat in Combination with Polyphenolic Antioxidant (−)-Epigallocatechin-3-Gallate (EGCG)

G. Wood, M. Nihal, C. T. Roelke, 2010, Pharmaceutical Research.

(-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma

H. Ahsan, H. Mukhtar, G. Wood, 2009, Cell cycle.

Expression of bcl‐2 protein and Ki‐67 nuclear proliferation antigen in benign and malignant cutaneous T‐cell infiltrates

R. Warnke, R. Dummer, B. Smoller, 1995, Journal of cutaneous pathology.

Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides.

R. Warnke, G. Wood, R. Hoppe, 1990, The American journal of pathology.

In situ quantitation of lymph node helper, suppressor, and cytotoxic T cell subsets in AIDS.

R. Warnke, G. Wood, B. Burns, 1986, Blood.

T-lymphocyte subsets in follicular lymphomas compared with those in non-neoplastic lymph nodes and tonsils.

R. Warnke, G. Wood, P. Dvoretsky, 1982, Human pathology.

The immunohistology of follicle lysis in lymph node biopsies from homosexual men.

R. Warnke, G. Wood, R. Dorfman, 1985, Blood.

Green tea: what's brewing?

G. Wood, 2000, Archives of dermatology.

Malignant Fibrous Histiocytoma Tumor Cells Resemble Fibroblasts

R. Warnke, R. Turner, R. Kempson, 1986, The American journal of surgical pathology.

Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.

O. Akilov, O. Donini, T. Kuzel, 2022, JAMA dermatology.

Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions.

R. Warnke, G. Wood, R. Hoppe, 1989, The Journal of investigative dermatology.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

R. Cowan, J. Scarisbrick, A. Pileri, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US Cutaneous Lymphoma Consortium.

L. Hughey, G. Wood, M. Kadin, 2014, Journal of the American Academy of Dermatology.

Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinomas

G. Wood, S. Snow, V. Spiegelman, 2014 .

Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cells.

E. Engleman, G. Wood, D. Charron, 1982, The Journal of investigative dermatology.

Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.

N. Polissar, J. Olerud, B. Wood, 2005, Archives of dermatology.

Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage.

R. Warnke, G. Wood, N. Warner, 1983, Journal of immunology.

Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease).

J. Sklar, T. Reynolds, L. Ellisen, 1987, The American journal of pathology.

Benign and malignant forms of erythroderma: cutaneous immunophenotypic characteristics.

G. Wood, R. Hoppe, E. Abel, 1988, Journal of the American Academy of Dermatology.

Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease.

R. Warnke, J. Sklar, M. Trela, 1986, The New England journal of medicine.

The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study

J. Scarisbrick, L. Cerroni, M. Tetzlaff, 2018, The American journal of surgical pathology.

The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis.

G. Wood, N. Stutz, Ryan D. Johnson, 2012, Journal of the American Academy of Dermatology.

On the trail of a new killer.

G. Wood, J. Guitart, 2009, Archives of dermatology.

Primary Cutaneous T-cell and B-cell Lymphomas

G. Wood, W. Piette, 2009 .

Folliculotropic mycosis fungoides with central nervous system involvement: demonstration of tumor clonality in intrafollicular T cells using laser capture microdissection.

Malcolm S. Ke, G. Wood, M. Nihal, 2003, Journal of the American Academy of Dermatology.

c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus

G. Wood, M. Nihal, 2016, Oncotarget.

Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.

R. Dummer, B. Smoller, G. Burg, 1996, Blood.

Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia.

T. E. Hoffman, R. Warnke, J. Sklar, 1989, The American journal of pathology.

Analysis of clonality in cutaneous T cell lymphoma and associated diseases.

G. Wood, 2001, Annals of the New York Academy of Sciences.

Poikilodermatous mycosis fungoides and atrophic large-plaque parapsoriasis exhibit similar abnormalities of T-cell antigen expression.

G. Wood, R. Hoppe, E. Abel, 1988, Archives of dermatology.

Immunophenotypic differences between dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides.

R. Warnke, G. Wood, L. Weiss, 1985, The American journal of pathology.

Immunohistochemistry and Molecular Biologic Techniques for Diagnosis, Staging and Monitoring of Cutaneous T-Cell Lymphoma

G. Wood, H. Greenberg, 2004 .

Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).

J. Sklar, G. Wood, H. Koh, 1994, The Journal of investigative dermatology.

Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.

R. Warnke, G. Wood, R. Hoppe, 1990, Journal of the American Academy of Dermatology.

Mycosis fungoides skin lesions contain CD8+ tumor‐infiltrating lymphocytes expressing an activated, MHC‐restricted cytotoxic T‐lymphocyte phenotype

R. Warnke, G. Wood, R. Hoppe, 1994, Journal of cutaneous pathology.

Cutaneous Follicular Lymphoma

R. Warnke, G. Wood, L. Weiss, 1986, The American journal of surgical pathology.

The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides.

R. Warnke, S. Horning, G. Wood, 1983, Blood.

Three Children with CD30+ Cutaneous Anaplastic Large Cell Lymphomas Bearing the t(2;5)(p23;q35) Translocation

S. Shurin, G. Wood, S. Kuerbitz, 2004, Pediatric dermatology.

Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation.

R. Warnke, G. Wood, B. Egbert, 1986, Journal of the American Academy of Dermatology.

A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.

T. Kuzel, G. Wood, J. Ryan, 2006, Journal of the American Academy of Dermatology.

Leu-6-expressing cells in lymph nodes: dendritic cells phenotypically similar to interdigitating cells.

R. Warnke, G. Wood, L. Weiss, 1986, Human pathology.

Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.

E. Engleman, G. Wood, D. Fishwild, 1985, Journal of immunology.

Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin.

G. Wood, A. Uluer, C. Crooks, 1995, The Journal of investigative dermatology.

Pan-leukocyte monoclonal antibody L3B12. Characterization and application to research and diagnostic problems.

R. Warnke, M. Link, G. Wood, 1984, American journal of clinical pathology.

The indeterminate cell proliferative disorder: report of a case manifesting as an unusual cutaneous histiocytosis.

R. Winkelmann, R. Turner, G. Wood, 1985, The Journal of dermatologic surgery and oncology.

Histiocytosis X cells and Langerhans cells: enzyme histochemical and immunologic similarities.

R. Turner, G. Wood, J. Beckstead, 1984, Human pathology.

Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: rationale for its use in combination therapy.

G. Wood, M. Nihal, Jianqiang Wu, 2014, Archives of biochemistry and biophysics.

Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.

G. Wood, 1998, Leukemia & lymphoma.

Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease

R. Dummer, B. Smoller, G. Burg, 1996 .

Identification of novel deletion Loci at 1p36 and 9p22-21 in melanocytic dysplastic nevi and cutaneous malignant melanomas.

G. Wood, M. Hussein, R. Tuthill, 2003, Archives of dermatology.

Immunohistology of pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. Evidence for their interrelationship with lymphomatoid papulosis.

R. Warnke, G. Wood, E. Abel, 1987, Journal of the American Academy of Dermatology.

Allergic contact dermatitis: novel immunohistologic features.

A. Volterra, G. Wood, B. Nickoloff, 1986, The Journal of investigative dermatology.

Methotrexate and Pralatrexate.

G. Wood, Jianqiang Wu, 2015, Dermatologic clinics.

Epigenetic regulation of apoptosis in cutaneous T-cell lymphoma (CTCL): implications for therapy with methotrexate, JAK inhibitors and resveratrol.

G. Wood, M. Nihal, A. Rook, 2021, The Journal of investigative dermatology.

SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis

G. Wood, M. Nihal, N. Ahmad, 2014, Cell cycle.

Selective enrichment of human epidermal cell subpopulations using monoclonal antibodies.

A. Oseroff, E. Engleman, G. Wood, 1983, The Journal of investigative dermatology.

Adult T‐cell leukemia/lymphoma in a patient from Romania: a case report and review of the literature

Dahua Zhang, G. Wood, N. Fett, 2008, Journal of cutaneous pathology.

Management of cutaneous lymphomas using a multidisciplinary approach.

L. Adler, G. Wood, S. Stevens, 1999, Archives of dermatology.

Subtypes of cutaneous T-cell lymphoma defined by expression of leu-1 and Ia.

R. Warnke, R. Miller, G. Wood, 1982, Blood.

c-CBL E3 Ubiquitin Ligase is Over-Expressed in Cutaneous T-Cell Lymphoma: Its Inhibition Promotes Activation Induced Cell Death

G. Wood, K. Salva, Jianqiang Wu, 2014, The Journal of investigative dermatology.

Anetoderma Arising in Cutaneous B-Cell Lymphoproliferative Disease

G. Wood, M. Nihal, P. Leboit, 2001, The American Journal of dermatopathology.

Enrichment of murine and human Langerhans cells with solid phase immunoabsorption using pan-leukocyte monoclonal antibodies.

E. Butcher, G. Wood, V. Morhenn, 1985, The Journal of investigative dermatology.

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Interleukin-12 Therapy of Cutaneous T-Cell Lymphoma Induces Lesion Regression and Cytotoxic T-Cell Responses

G. Wood, S. Lessin, A. Rook, 2016 .

The Role for Interleukin‐12 Therapy of Cutaneous T Cell Lymphoma

T. Kuzel, G. Wood, L. Showe, 2001, Annals of the New York Academy of Sciences.

Expression of Leu-8 antigen, a majority T-cell marker, is uncommon in mycosis fungoides.

R. Warnke, G. Wood, R. Hoppe, 1985, The Journal of investigative dermatology.

Maturational and functional diversity of human B lymphocytes delineated with anti-Leu-8.

E. Engleman, G. Wood, G. Kansas, 1985, Journal of immunology.

Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.

G. Wood, M. Nihal, E. Vonderheid, 2009, The Journal of investigative dermatology.

Upregulation of PI3K/AKT/mTOR, FABP5 and PPARβ/δ in Human Psoriasis and Imiquimod-induced Murine Psoriasiform Dermatitis Model.

V. Adhami, H. Mukhtar, B. Longley, 2016, Acta dermato-venereologica.

Delphinidin, a dietary antioxidant, induces human epidermal keratinocyte differentiation but not apoptosis: studies in submerged and three‐dimensional epidermal equivalent models

V. Adhami, H. Mukhtar, G. Wood, 2013, Experimental dermatology.

Using molecular biologic analysis of T-cell receptor gene rearrangements to stage cutaneous T-cell lymphoma.

G. Wood, 1998, Archives of dermatology.

Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.

G. Wood, S. Stevens, K. Cooper, 2007, Journal of the American Academy of Dermatology.

Analysis of tumor-infiltrating lymphocytes in cutaneous squamous cell carcinoma.

C. Elmets, G. Wood, A. Haeffner, 1997, Archives of dermatology.

Detection of low-level tumor cells in allergic contact dermatitis induced by mechlorethamine in patients with mycosis fungoides.

J. Sklar, G. Wood, H. Veelken, 1996, The Journal of investigative dermatology.

Lymphocyte activation in cutaneous T-cell lymphoma.

G. Wood, 1995, Journal of Investigative Dermatology.

Molecular staging of cutaneous T-cell lymphoma: evidence for systemic involvement in early disease.

J. Sklar, G. Wood, H. Veelken, 1995, The Journal of investigative dermatology.

Clonal rearrangement of the T cell receptor beta gene in the circulating lymphocytes of erythrodermic follicular mucinosis.

M. Cleary, G. Wood, R. Hoppe, 1988, Blood.

T-cell antigen deficiencies and clonal rearrangements of T-cell receptor genes in pagetoid reticulosis (Woringer-Kolopp disease).

R. Warnke, J. Sklar, G. Wood, 1988, The New England journal of medicine.

Woringer-Kolopp disease (pagetoid reticulosis). Four cases with histopathologic, ultrastructural, and immunohistologic observations.

G. Wood, R. Hoppe, J. Beckstead, 1984, Archives of dermatology.

Histiocytic malignancies: Morphologic, immunologic, and enzymatic heterogeneity

R. Warnke, S. Horning, R. Turner, 1984, The American journal of surgical pathology.

Molecular biology techniques for the diagnosis of cutaneous T-cell lymphoma.

R. Dummer, G. Wood, C. Crooks, 1994, Dermatologic clinics.

The immunohistology of non-T cells in the acquired immunodeficiency syndrome.

R. Warnke, G. Wood, B. Burns, 1985, The American journal of pathology.

The Cells of Giant Cell Tumor of Tendon Sheath Resemble Osteoclasts

R. Warnke, R. Kempson, G. Wood, 1988, The American journal of surgical pathology.

Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.

R. Warnke, L. Picker, G. Wood, 1987, The American journal of pathology.

The immunologic phenotyping of bone marrow biopsies and aspirates: frozen section techniques.

R. Warnke, G. Wood, 1982, Blood.

Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.

G. Wood, Y. Kim, E. Olsen, 2001, Archives of dermatology.

Nonmelanoma Skin Cancers

G. Wood, S. Snow, V. Spiegelman, 2020, Abeloff's Clinical Oncology.

Erythema gyratum Repens-like eruption in Sézary syndrome: evidence for the role of a dermatophyte.

B. Longley, G. Wood, D. Bennett, 2019, Cutis (New York, N.Y.).

Apoptosis and melanoma: molecular mechanisms

G. Wood, M. Hussein, A. Haemel, 2003, The Journal of pathology.

Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential.

G. Wood, M. Nihal, S. Stevens, 2003, Human pathology.

Histopathology and genetics of cutaneous T-cell lymphoma.

B. Smoller, M. Santucci, G. Wood, 2003, Hematology/oncology clinics of North America.

Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy.

R. Warnke, J. Sklar, M. Cleary, 1985, The New England journal of medicine.

A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis.

G. Wood, M. Duvic, A. Rook, 2010, Journal of the American Academy of Dermatology.

Restructuring dermatology education at Cleveland medical centers affiliated with Case Western Reserve University.

B. Elewski, M. Chren, R. Brodell, 1996, Archives of Dermatology.

Differentiation and clonality of lesional lymphocytes in pityriasis lichenoides chronica.

G. Wood, D. Mikkola, S. Shieh, 2001, Archives of dermatology.

Cutaneous lymphoid hyperplasia

R. Warnke, L. Picker, G. Wood, 1989 .

Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.

G. Wood, R. Hoppe, E. Abel, 1990, Current problems in cancer.

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

A. Oseroff, F. Craig, J. Reuben, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses.

G. Wood, S. Lessin, A. Rook, 1999, Blood.

The Histogenesis of Kaposi's Sarcoma

G. Wood, J. Beckstead, V. Fletcher, 1986 .

Defining early mycosis fungoides.

Nicola Pimpinelli, Werner Kempf, Masahiro Takigawa, 2005, Journal of the American Academy of Dermatology.

Differentiation and clonality of lesional lymphocytes in small plaque parapsoriasis.

B. Smoller, G. Wood, A. Haeffner, 1995, Archives of dermatology.

Clonal dermatitis: a potential precursor of CTCL with varied clinical manifestations.

G. Wood, J. Siddiqui, M. Misra, 1997 .

Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise

V. Adhami, H. Mukhtar, G. Wood, 2012, Experimental dermatology.

Use of recombinant interferon gamma administered intramuscularly for the treatment of psoriasis.

G. Wood, V. Morhenn, E. Farber, 1987, Archives of dermatology.

Microsatellite instability and alterations of mismatch repair protein expression in choroidal melanomas.

G. Wood, D. Albert, M. Hussein, 2005, Archives of ophthalmology.

Drug-Induced Pseudo-Sezary Syndrome: A Case Report and Literature Review

G. Wood, M. Reeder, 2015, The American Journal of dermatopathology.

EXPRESSION OF CLASS II MAJOR HISTOCOMPATIBILITY ANTIGENS BY KERATINOCYTES IN CUTANEOUS T CELL LYMPHOMA

R. Warnke, G. Wood, R. Hoppe, 1994, International journal of dermatology.

G. Wood, M R Hussein, A K Haemel, 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Novel histiocytoses considered in the context of histiocyte subset differentiation.

G. Wood, R. Haber, 1993, Archives of dermatology.

Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.

S. K. Szabo, G. Wood, Lili Liu, 2012, Archives of dermatology.

No evidence of KSHV/HHV-8 in mycosis fungoides or associated disorders.

G. Wood, C. Giam, S. Purvis, 1997, The Journal of investigative dermatology.

Kaposi sarcoma-associated herpesvirus/human herpesvirus type 8 and Epstein-Barr virus in iatrogenic Kaposi sarcoma.

G. Wood, D. Leonard, C. Giam, 1997, Archives of dermatology.

Molecular aspects of melanocytic dysplastic nevi.

G. Wood, M. Hussein, 2002, The Journal of molecular diagnostics : JMD.

Building Bridges in Cancer: Mismatch Repair and Microsatellite Instability

G. Wood, M. Hussein, 2002, The American Journal of dermatopathology.

No evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphoma.

R. Dummer, G. Burg, G. Wood, 1997, The American journal of pathology.

Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA.

I. Weissman, R. Warnke, G. Wood, 1991, The American journal of pathology.

Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes.

G. Wood, T. Tedder, G. Kansas, 1991, Journal of immunology.

Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sezary syndrome.

J. Sklar, G. Wood, R. Hoppe, 1989, The Journal of investigative dermatology.

T-cell receptor and immunoglobulin gene rearrangements in diagnosing skin disease.

G. Wood, 2001, Archives of dermatology.

Quantitation of T-cell DNA in cutaneous lymphoid infiltrates.

J. Sklar, G. Wood, C. Crooks, 1991, The American journal of pathology.

Cutaneous lymphoproliferative disorders: strategies for molecular biological analysis and their major findings

G. Wood, 2004, Springer Seminars in Immunopathology.

Polymerase chain reaction/denaturing gradient gel electrophoresis (PCR/DGGE): sensitivity, band pattern analysis, and methodologic optimization.

G. Wood, A. Uluer, 1999, The American Journal of dermatopathology.

Mutations in ras oncogenes: Rare events in ultraviolet B radiation‐induced mouse skin tumorigenesis

Sikandar G. Khan, R. Mohan, R. Agarwal, 1996, Molecular carcinogenesis.

Polo‐like kinase 1 (Plk1) in cutaneous T‐cell lymphoma

G. Wood, M. Nihal, N. Stutz, 2011, The British journal of dermatology.

The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in CTCL Can Be Reproduced by ΔNp73 Depletion.

G. Wood, A. Rook, Jaehyuk Choi, 2022, The Journal of investigative dermatology.

CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides.

R. Warnke, G. Wood, L. Medeiros, 1995, Journal of the American Academy of Dermatology.

Detection of human T-cell lymphotrophic virus type I in archival tissue specimens.

G. Wood, M. Kikuchi, M. Takeshita, 1996, Archives of dermatology.

Cutaneous &ggr;&dgr; T-cell Lymphomas: A Spectrum of Presentations With Overlap With Other Cytotoxic Lymphomas

D. Weisenburger, G. Wood, D. Ivan, 2012, The American journal of surgical pathology.

Alterations of Mismatch Repair Protein Expression in Benign Melanocytic Nevi, Melanocytic Dysplastic Nevi, and Cutaneous Malignant Melanomas

G. Wood, R. Tuthill, E. Roggero, 2001, The American Journal of dermatopathology.

Expression of CD31/PECAM-1 (platelet endothelial cell adhesion molecule 1) by blastic plasmacytoid dendritic cell neoplasms.

B. Longley, G. Wood, J. Guitart, 2014, JAMA dermatology.

Disseminated dermal dendrocytomas. A new cutaneous fibrohistiocytic proliferative disorder?

G. Wood, C. Griffiths, B. Nickoloff, 1990, The American journal of surgical pathology.

The immunohistology of the persistent generalized lymphadenopathy syndrome (PGL).

R. Warnke, J. Lifson, E. Engleman, 1986, American journal of clinical pathology.

The varied histopathology of lymphadenopathy in the homosexual male.

G. Wood, B. Burns, R. Dorfman, 1985 .

Necrolytic acral erythema associated with hepatitis C: effective treatment with interferon alfa and zinc.

G. Wood, W. Dorner, M. Zaim, 2000, Archives of dermatology.

A Phase III Skin Cancer Chemoprevention Study of DFMO: Long-term Follow-up of Skin Cancer Events and Toxicity

Eneida A. Mendonça, KyungMann Kim, E. Mendonça, 2012, Cancer Prevention Research.

Drill- and suction-generated noise in mastoid surgery.

G. Wood, G. McCandless, J. Parkin, 1980, Archives of otolaryngology.

Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.

K. Satyshur, V. Adhami, H. Mukhtar, 2017, Antioxidants & redox signaling.

CD5 monoclonal antibodies react with human peripheral blood dendritic cells.

G. Wood, P. Freudenthal, 1992, The American journal of pathology.

Genomic instability in radial growth phase melanoma cell lines after ultraviolet irradiation

G. Wood, M. Hussein, A. Haemel, 2005, Journal of Clinical Pathology.

hMLH1 and hMSH2 gene mutations are present in radial growth‐phase cutaneous malignant melanoma cell lines and can be induced further by ultraviolet‐B irradiation

G. Wood, M. Hussein, 2003, Experimental dermatology.

CD45 epitope mapping of human CD1a+ dendritic cells and peripheral blood dendritic cells.

R. Warnke, R. Steinman, G. Wood, 1991, The American journal of pathology.

Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC.

L. Schwartz, J. Scarisbrick, E. Guenova, 2021, Blood.

Langerhans cells react with pan-leukocyte monoclonal antibody: ultrastructural documentation using a live cell suspension immunoperoxidase technique.

E. Butcher, G. Wood, V. Morhenn, 1984, The Journal of investigative dermatology.

Absence of Borrelia burgdorferi DNA in cutaneous B‐cell lymphomas from the United States

L. Cerroni, B. Smoller, G. Wood, 2001, Journal of cutaneous pathology.

Microsatellite instability and its relevance to cutaneous tumorigenesis

G. Wood, M. Hussein, 2002, Journal of cutaneous pathology.

Human Langerhans cells express a novel form of the leukocyte common antigen (CD45).

G. Wood, A. Schwandt, P. Szwejbka, 1998, The Journal of investigative dermatology.

Hematopoietic Tumors: Normal or Abnormal Models of Leukocyte Differentiation?

C. Balch, L. Lanier, G. Wood, 1983 .

Complications of therapeutic apheresis, including a fatal case with pulmonary vascular occlusion.

G. Wood, R. Wall, M. Rubenstein, 1983, The American journal of medicine.

Primary cutaneous sarcomatoid anaplastic large-cell lymphoma.

M. G. Fleming, G. Wood, N. Stutz, 2012, The American Journal of dermatopathology.

No detection of HTLV‐I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T‐cell lymphoma

G. Wood, R. Böni, G. Burg, 1996, The British journal of dermatology.

Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression

R. Advani, G. Wood, S. Horwitz, 2012 .

Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.

B. Strober, A. Kimball, G. Wood, 2013, JAMA dermatology.

Epigenetically Enhanced PDT Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT, Resulting in Greater Extrinsic and Overall Apoptosis of Cutaneous T‐cell Lymphoma

G. Wood, Youn H. Kim, Z. Rahbar, 2018, Photochemistry and photobiology.

Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T‐Cell Lymphoma

G. Wood, K. Salva, 2015, Photochemistry and photobiology.

Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T‐Cell Lymphoma

G. Wood, K. Salva, 2015, Photochemistry and photobiology.

In situ localization of HuHF serine protease mRNA and cytotoxic cell-associated antigens in human dermatoses. A novel method for the detection of cytotoxic cells in human tissues.

I. Weissman, R. Warnke, G. Wood, 1988, The American journal of pathology.

Cutaneous lymphoid hyperplasias.

G. Wood, A. Gilliam, 2000, Seminars in cutaneous medicine and surgery.

Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas

G. Wood, Min Sun, R. Tuthill, 2002, Molecular carcinogenesis.

Fatal post-transfusion acquired immunodeficiency in a heterosexual man: quantitative lymph node immunopathology.

R. Warnke, G. Wood, B. Burns, 1988, Human pathology.

Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi

G. Wood, Min Sun, M. Hussein, 2001, Journal of cutaneous pathology.

Tumor stage mycosis fungoides in a patient treated with long-term corticosteroids for asthma and atopic-like dermatitis.

G. Wood, B. Nickoloff, E. Abel, 1986, The Journal of dermatologic surgery and oncology.

Endobronchial tuberculosis in children. A case report and review.

G. Wood, C. Gonzalez, R. Albus, 1990, International Journal of Pediatric Otorhinolaryngology.

A bullous variant of Kaposi's sarcoma in an elderly female.

G. Wood, B. Nickoloff, B. Recht, 1986, The Journal of dermatologic surgery and oncology.

Malignant histiocytosis X report of a rapidly fatal case in an elderly man

G. Wood, J. Beckstead, D. G. Deneau, 1984, Cancer.

Chronic Infectious Mononucleosis Syndrome, Pancytopenia, and Polyclonal B‐Lymphoproliferation Terminating in Acute Lymphoblastic Leukemia

J. Finlay, M. Link, G. Wood, 1986, The American journal of pediatric hematology/oncology.

Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma12

G. Wood, J. Okhovat, Youn H. Kim, 2018, Neoplasia.

Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL).

G. Wood, M. Nihal, E. Vonderheid, 2011, Archives of biochemistry and biophysics.

c-CBL E3 Ubiquitin Ligase Expression Increases Across the Spectrum of Benign and Malignant T-Cell Skin Diseases

G. Wood, M. Reeder, K. Salva, 2017, The American Journal of dermatopathology.

Evidence that mycosis fungoides mf and transformed mf arise from the same t cell clone

R. Warnke, J. Sklar, G. Wood, 1991 .

Gamma Interferon‐Induced Expression of Class II Major Histocompatibility Complex Antigens by Human Keratinocytes Effects of Conditions of Culture

G. Wood, V. Morhenn, VERA B. MORHENN, 1988, Annals of the New York Academy of Sciences.

EBV+ mucocutaneous ulcers in the setting of pre-existing cutaneous T-cell lymphoproliferative disorders: A report of 2 cases

B. Longley, G. Wood, J. J. Inda, 2018, JAAD case reports.

The immunologic phenotyping of bone marrow biopsies and aspirates: frozen section techniques

R. Warnke, G. Wood, 1982 .

Primary Cytotoxic T Cell Lymphomas Harbor Recurrent Targetable Alterations in the JAK-STAT Pathway.

Ryanne A. Brown, J. Aster, G. Wood, 2021, Blood.

HTLV-I and CTCL: the link is missing.

G. Wood, S. Lessin, A. Rook, 1996, The Journal of investigative dermatology.

Possible association of cutaneous Rosai-Dorfman disease and chronic Crohn disease: a case series report.

G. Wood, D. Bennett, P. B. Odland, 2014, JAMA dermatology.

The immunohistology of lymph nodes in HIV infection: a review.

G. Wood, G S Wood, 1990, Progress in AIDS pathology.

Erratum: Three children with CD30+ cutaneous anaplastic large cell lymphomas bearing the t(2;5)(p23;q35) translocation (Pediatric Dermatology (2004) 21 (212-217))

S. Shurin, G. Wood, S. Kuerbitz, 2004 .

Detection of clonally restricted immunoglobulin heavy chain gene rearrangements in normal and lesional skin: analysis of the B cell component of the skin-associated lymphoid tissue and implications for the molecular diagnosis of cutaneous B cell lymphomas.

G. Wood, M. Nihal, D. Mikkola, 2000, The Journal of molecular diagnostics : JMD.

A family of cell-surface glycoproteins defined by a putative anti-endothelial cell receptor antibody in man.

G. Wood, G. Kansas, M. Dailey, 1989, Journal of Immunology.

Guest Editorial’s Introduction

G. Wood, H. Mukhtar, 2011 .

B. Strober, A. Kimball, G. Wood, 2013, JAMA dermatology.

Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?

J. Scarisbrick, G. Wood, S. Whittaker, 2014, The British journal of dermatology.

Primary Cutaneous Aggressive Epidermotropic Cytotoxic T-cell Lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas

M. Tetzlaff, G. Wood, D. Ivan, 2017, Modern Pathology.

Immunop henotypic Dierences Between Dermatopath ic Lymphadenopathy and Lymph Node Involvement in Mycosis Fungoides

R. Warnke, G. Wood, L. Weiss, 2007 .

Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinomas

G. Wood, S. Snow, V. Spiegelman, 2014 .